1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione
CAS848398-40-3
1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione (CAS 848398-40-3, C6H6N2O3) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
![Chemical structure of 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione](https://chemsigma.com/chemicalStructure/84/848398-40-3.png)
- CAS No.
- 848398-40-3
- Formula
- C6H6N2O3
- Mol. weight
- 154.12 g/mol
Chemical Specifications
Identifiers
| CAS number | 848398-40-3 |
|---|---|
| Product name | 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione |
| Molecular formula | C6H6N2O3 |
| Molecular weight | 154.12 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione?
The CAS Registry Number of 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione is 848398-40-3.
What is the molecular formula and molecular weight of 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione?
The molecular formula of 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione is C6H6N2O3, and its molecular weight is 154.12 g/mol.
How can I request a quotation for 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione?
Send an inquiry for 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione (CAS 848398-40-3) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 1H,2H,3H,4H,5H,7H-furo[3,4-d]pyrimidine-2,4-dione
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.